IMI 2009 call for proposals launched
The Innovative Medicines Initiative Joint Undertaking (IMI JU) is issuing a call for proposals. IMI JU is a unique pan-European public private partnership aiming to foster collaboration between all relevant stakeholders including large and small biopharmaceutical and healthcare companies, regulators, academia and patients' organisations. The IMI 2009 call for proposals addresses nine topics: - imaging biomarkers for anticancer drug development; - new tools for target validation to improve drug efficacy; - molecular biomarkers: accelerating cancer therapy development and refining patient care; - identification and development of rapid point-of-care diagnostic tests for bacterial diagnosis to facilitate conduct of clinical trials and clinical practice; - understanding aberrant adaptive immunity mechanisms; - translational research in chronic immune-mediated disease: bridging between animal models and humans; - drug/disease modelling: library and framework; - open pharmacological space; - electronic health records (EHR). The European Community will co-fund the IMI JU call to a maximum amount of EUR 76.8 million.To see the full details of the call, please consult the following web address: http://cordis.europa.eu/fp7/calls/(opens in new window) Or visit the IMI website: http://www.imi.europa.eu/calls-02-stage1_en.html(opens in new window)